These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29549276)

  • 21. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.
    Olesen B; Hansen DS; Nilsson F; Frimodt-Møller J; Leihof RF; Struve C; Scheutz F; Johnston B; Krogfelt KA; Johnson JR
    J Clin Microbiol; 2013 Jun; 51(6):1779-85. PubMed ID: 23554186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of chromosomal blaCTX-M-15 in Escherichia coli O25b-B2-ST131 isolates from the Kinki region of Japan.
    Hirai I; Fukui N; Taguchi M; Yamauchi K; Nakamura T; Okano S; Yamamoto Y
    Int J Antimicrob Agents; 2013 Dec; 42(6):500-6. PubMed ID: 24091130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
    Hefzy EM; Hassuna NA
    Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extraintestinal pathogenic Escherichia coli O1:K1:H7/NM from human and avian origin: detection of clonal groups B2 ST95 and D ST59 with different host distribution.
    Mora A; López C; Dabhi G; Blanco M; Blanco JE; Alonso MP; Herrera A; Mamani R; Bonacorsi S; Moulin-Schouleur M; Blanco J
    BMC Microbiol; 2009 Jul; 9():132. PubMed ID: 19583828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain.
    Cortés P; Blanc V; Mora A; Dahbi G; Blanco JE; Blanco M; López C; Andreu A; Navarro F; Alonso MP; Bou G; Blanco J; Llagostera M
    Appl Environ Microbiol; 2010 May; 76(9):2799-805. PubMed ID: 20228098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates.
    Mora A; Herrera A; Mamani R; López C; Alonso MP; Blanco JE; Blanco M; Dahbi G; García-Garrote F; Pita JM; Coira A; Bernárdez MI; Blanco J
    Appl Environ Microbiol; 2010 Nov; 76(21):6991-7. PubMed ID: 20817805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden.
    Helldal L; Karami N; Welinder-Olsson C; Moore ER; Åhren C
    BMC Microbiol; 2017 Jan; 17(1):8. PubMed ID: 28061803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Multiplex PCR Method and Genome Sequence-Based Analog for High-Resolution Subclonal Assignment and Characterization of Escherichia coli Sequence Type 131 Isolates.
    Johnston BD; Gordon DM; Burn S; Johnson TJ; Weber BP; Miller EA; Johnson JR
    Microbiol Spectr; 2022 Jun; 10(3):e0106422. PubMed ID: 35604132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The characterization and antibiotic resistance profiles of clinical Escherichia coli O25b-B2-ST131 isolates in Kuwait.
    Dashti AA; Vali L; El-Shazly S; Jadaon MM
    BMC Microbiol; 2014 Aug; 14():214. PubMed ID: 25163534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-Genome Analysis of Antimicrobial-Resistant and Extraintestinal Pathogenic Escherichia coli in River Water.
    Gomi R; Matsuda T; Matsumura Y; Yamamoto M; Tanaka M; Ichiyama S; Yoneda M
    Appl Environ Microbiol; 2017 Mar; 83(5):. PubMed ID: 27986723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spread of CTX-Type Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates of Epidemic Clone B2-O25-ST131 Among Dogs and Cats in Japan.
    Kawamura K; Sugawara T; Matsuo N; Hayashi K; Norizuki C; Tamai K; Kondo T; Arakawa Y
    Microb Drug Resist; 2017 Dec; 23(8):1059-1066. PubMed ID: 28380311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole genome analyses of CMY-2-producing Escherichia coli isolates from humans, animals and food in Germany.
    Pietsch M; Irrgang A; Roschanski N; Brenner Michael G; Hamprecht A; Rieber H; Käsbohrer A; Schwarz S; Rösler U; Kreienbrock L; Pfeifer Y; Fuchs S; Werner G;
    BMC Genomics; 2018 Aug; 19(1):601. PubMed ID: 30092762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.
    Johnson JR; Johnston B; Clabots C; Kuskowski MA; Castanheira M
    Clin Infect Dis; 2010 Aug; 51(3):286-94. PubMed ID: 20572763
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Zhong YM; Liu WE; Meng Q; Li Y
    Infect Drug Resist; 2019; 12():2693-2702. PubMed ID: 31564918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bloodstream infections with
    Zhong Y; Zhang X; Liu W; Yang F; Yan Q; Liu Q; Li Y; Li H; Zou M
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1521-1526. PubMed ID: 30613024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.
    Johnson JR; Urban C; Weissman SJ; Jorgensen JH; Lewis JS; Hansen G; Edelstein PH; Robicsek A; Cleary T; Adachi J; Paterson D; Quinn J; Hanson ND; Johnston BD; Clabots C; Kuskowski MA;
    Antimicrob Agents Chemother; 2012 May; 56(5):2364-70. PubMed ID: 22354301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.
    Rodríguez I; Figueiredo AS; Sousa M; Aracil-Gisbert S; Fernández-de-Bobadilla MD; Lanza VF; Rodríguez C; Zamora J; Loza E; Mingo P; Brooks CJ; Cantón R; Baquero F; Coque TM
    mSphere; 2021 Dec; 6(6):e0086821. PubMed ID: 34935444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended-spectrum β-lactamase-producing Escherichia coli isolated from healthy humans in Mexico, including subclone ST131-B2-O25:H4-H30-Rx.
    Cortés-Cortés G; Lozano-Zarain P; Torres C; Alonso CA; Ríos-Torres AM; Castañeda M; López-Pliego L; Navarro A; Del Carmen Rocha-Gracia R
    J Glob Antimicrob Resist; 2017 Jun; 9():130-134. PubMed ID: 28552831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
    Kim YA; Lee K; Chung JE
    BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.